Use of ALK 5 inhibitors to modulate or inhibit myostatin activity leading to increased lean tissue accretion in animals

Details for Australian Patent Application No. 2005280496 (hide)

International Classifications

Event Publications

8 February 2007 PCT application entered the National Phase

PCT publication WO2006/025988 Priority application(s): WO2006/025988

24 May 2007 Assignment before Grant

Schering-Plough Ltd. The application has been assigned to Schering-Plough Pty. Limited

8 October 2009 Application Accepted

Published as AU-B-2005280496

25 February 2010 Standard Patent Sealed

23 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.